✦ LIBER ✦

Dose escalation study of irinotecan combined with carboplatin for advanced non-small-cell lung cancer

✍ Scribed by Koji Takeda; Shunichi Negoro; Nobuhide Takifuji; Takashi Nitta; Naruo Yoshimura; Kazuhiko Terakawa; Masahiro Fukuoka

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of escalating doses of

✍ Fumihiro Oshita; Kouzo Yamada; Yuji Kato; Mizuki Ikehara; Kazumasa Noda; Gaku Ta 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 154 KB

Phase II study of irinotecan combined wi

✍ Minoru Fukuda; Mikio Oka; Hiroshi Soda; Akitoshi Kinoshita; Masaaki Fukuda; Seij 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 197 KB

Phase II study of carboplatin combined w

✍ Lian Jiang; Dao-yuan Wang; Zhi-hua Zhu; Liang-fa Tang; Xin-heng Hou; Hong-da Zha 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 242 KB

Phase I study of daily S-1 combined with

✍ Osamu Ishimoto; Takashi Ishida; Yoshihiro Honda; Mitsuru Munakata; Shunichi Suga 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 218 KB

Dose escalation and pharmacokinetic stud

✍ John R. Murren; Kathleen Peccerillo; Susan A. DiStasio; Xin Li; Janine J. Leffer 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 119 KB

A dose-escalation study of pemetrexed an

✍ Athanasios Kotsakis; Sophia Agelaki; Nikolaos Vardakis; George Stathopoulos; Lam 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 184 KB